Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Abstract

In 2002, the crude incidence rates of carcinoma of the head and neck (ICD, 10th revision C00–C10, C12–C14, C32) in Europe were 36/100 000/year in the male population and 7/100 000/year for females, while the corresponding mortality rates were 18 and 3/100 000/year. On the European scale, head and neck cancer accounts for 139 000 new cases per year. More than 90% of head and neck malignancies are squamous cell carcinomas.